ConforMIS Announces Proposed Public Offering of Common Stock
Jan 24, 2018 21:01 pm UTC| Business
BILLERICA, Mass., Jan. 24, 2018 -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement...
Albireo Announces Proposed Public Offering of Common Stock
Jan 24, 2018 21:01 pm UTC| Business
BOSTON, Jan. 24, 2018 -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today that it has commenced an underwritten public...
ShotSpotter and Verizon Partner to Expand Gunshot Detection Through City Street Lights
Jan 24, 2018 21:01 pm UTC| Business
NEWARK, Calif., Jan. 24, 2018 -- ShotSpotter (NASDAQ:SSTI) today announced an agreement with Verizon to bring the ShotSpotter solution to cities by leveraging Verizon's Light Sensory Network, an IoT platform deployed on...
Novelion Therapeutics Announces Cost Reduction Plans and Capital Structure Review
Jan 24, 2018 21:01 pm UTC| Business
VANCOUVER, British Columbia, Jan. 24, 2018 -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare metabolic diseases,...
Jan 24, 2018 21:00 pm UTC| Business
Vancouver, Jan. 24, 2018 -- M·Y·O Cosmetic Cases®, creating liberating beauty solutions, is thrilled to have their award-winning product, the M·Y·O Cosmetic Clutch™, in the official 60th GRAMMY Awards® Presenter and...
Kimball International Announces New Presidents of National Office Furniture and Kimball Hospitality
Jan 24, 2018 21:00 pm UTC| Business
JASPER, Ind., Jan. 24, 2018 -- Kimball International, Inc. (NASDAQ:KBAL) today announced the following appointments to the President, National Office Furniture and President, Kimball Hospitality executive leadership...
Jan 24, 2018 21:00 pm UTC| Business
Novartis Pharmaceuticals will commercialize investigational voretigene neparvovec when and if approved in Europe and all other markets outside the U.S.; Spark Therapeutics retains U.S. commercial rights for LUXTURNA™...
China Signals Subtle Treasury Pullback: Banks Urged to Ease US Debt Exposure
China Signals Quiet Treasury Trim: Banks Told to Ease Up on US Debt
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma